Cell-based influenza vaccine approved for kids 2+
09 March, 2022Cell-based seasonal influenza vaccine Flucelvax Quad has been approved for Australian children aged two years and older.
Mild COVID-19 linked to changes in brain structure: study
09 March, 2022New research reveals the damaging effects of COVID-19 and improves our understanding of how the disease spreads through the central nervous system.
SHPA releases pharmacy standard for heart disease
08 March, 2022The new pharmacy practice standard recommends patient to pharmacist ratios and quality improvement indicators specific to specialist cardiology pharmacists.
Royal Victorian Eye and Ear Hospital implements PSML
07 March, 2022The Royal Victorian Eye and Ear Hospital is said to be the first hospital in Australia to implement the Pharmacist Shared Medicines List medicine safety initiative.
Hepatitis B: new recommendations for clinicians
07 March, 2022New recommendations for the management of hepatitis B have been released in a bid to improve awareness of chronic hepatitis B among clinicians and to increase detection of cases that currently remain undiagnosed.
Landmark clinical practice guidelines for children with CMT
04 March, 2022Charcot-Marie-Tooth disease is the most common childhood inherited nerve disorder. Yet until now, there have been no guidelines to help patients manage their condition.
Missing surgeries will take some time to work through: APHA
04 March, 2022The latest APRA data shows 11,000 anticipated admissions were missing from private hospitals in the last quarter of 2021.
Breast cancer: how often does overdiagnosis occur?
02 March, 2022A new study suggests that overdiagnosis, or the finding of tumours that may never have progressed or caused harm in a woman's lifetime, occurs in about 15% of screen-detected cancers.
COVID-19 antiviral available on the PBS
02 March, 2022Australians at risk of progressing to severe COVID-19 disease will now be eligible to access an oral antiviral treatment through the PBS.
New rare blood disease treatment on PBS
28 February, 2022Ultomiris (ravulizumab) will be listed for the first time for patients with paroxysmal nocturnal haemoglobinuria.
Liver cancer: non-invasive treatment trial to begin soon
25 February, 2022A new non-invasive treatment for inoperable early-stage liver cancer is set to be trialled across Australia this year.
Global trial to investigate fractional COVID-19 boosters
23 February, 2022Up to 3300 healthy adults across Australia, Indonesia and Mongolia will be invited to take part in a global trial investigating the impact of administering reduced COVID-19 booster shots.
Music for stem cells: how soundwaves could help regrow bones
22 February, 2022Researchers have used soundwaves to turn stem cells into bone cells, in a tissue engineering advance that could help regrow bones.
Mechanical blood clot removal improves outcomes for stroke patients
21 February, 2022In an international study of 1000 stroke patients, nearly half of survivors achieved good to ideal outcomes at three months after the stroke if they had received mechanical clot removal.
Menopause: AIA, Aus Menopause Society partner to combat misdiagnoses
15 February, 2022AIA Australia believes that there is a significant need for increased education and access to evidence-based information about menopause to ensure correct diagnosis.
